In addition to the cell cycle and cell division, Cell Cycle covers all topics from man to virus, from DNA to RNA, from aging to development, from cell senescence to stem cells, from apoptosis to autophagy, from cancer to neurobiology, from molecular and theoretical biology to medicine and therapy.
Cell Cycle is indexed in Medline/PubMed and in the Science Citation Index Expanded.
2008 Impact Factor: 4.12
Cell Cycle utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.
There are 3 submission tracks to choose from:
M.V. Blagosklonny, M.D., Ph.D.
Roswell Park Cancer Institute
Buffalo, NY
Email the Managing Editor.
Landes Bioscience gladly participates in the World Health Organization's Access to Research Initiative (HINARI) to provide free online access to all papers published in Cell Cycle to scientists in developing countries worldwide.

As of April 15, 2009, Mikhail (Misha) Blagosklonny, MD, PhD (pictured right), has been appointed Member/Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Cancer Institute, Buffalo, NY. Dr. Blagosklonny is the author of over 170 research articles, reviews and book chapters. He is the Editor-in-Chief of Cell Cycle and also serves as an Associate Editor for Cancer Biology & Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, International Journal of Cancer, The American Journal of Pathology and PLOS ONE. His research interests range from molecular and cellular biology to clinical investigations and include signal transduction, cell cycle, cellular senescence, and anticancer therapeutics with an emphasis on translation of basic science into new anticancer strategies. He extended the study of signal transduction pathways from cancer to aging, revealing potential targets for slowing down aging and age-related diseases. “Misha is a pre-eminent researcher, who developed unique concepts on cancer biology and therapy ,” according to Andrei V. Gudkov, Senior Vice-President of Basic Science at Roswell Park and Chairman of the Department of Cell Stress Biology (pictured left). “The presence of Misha will facilitate the development of new anti-cancer strategies and methods of cancer therapy and prevention. Here at Roswell, we are very enthusiastic about his recruitment. We share numerous ideas and approaches, including protection of normal cells from radio- and chemotherapy, selective combinations of anticancer drugs, tissue-specific therapy (anti-tissue therapy) of cancer, and prevention of cancer by slowing down organismal aging”.